Arun BK, Han HS, Kaufman B, Wildiers H, et al. Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial. Eur J Cancer 2021;154:35-45.
PMID: 34243076